Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | ABCG2 | Q9UNQ0 | 4/20 | 0.58 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.55 |
| ▸ | MAOA | P21397 | 2/20 | 0.51 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.50 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | AURKA | O14965 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | ERN1 | O75460 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | HTR1A | P08908 | 1/20 | 0.46 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL715946 | 0.88 | ALDH1A1 (0.74) | ALDH1A1SMN1; SMN2ABCG2PTGS2MAOA | |
| SCHEMBL290189 | 0.88 | ALDH1A1 (0.74) | ALDH1A1SMN1; SMN2ABCG2PTGS2MAOA | |
| SCHEMBL6792466 | 0.81 | ABCG2 (0.58) | ALDH1A1SMN1; SMN2ABCG2CYP1A1CYP1B1 | |
| SCHEMBL10661702 | 0.81 | MAPT (0.69) | ALDH1A1SMN1; SMN2CYP1A1CYP1B1CYP1A2 | |
| SCHEMBL6782178 | 0.81 | MAPT (0.69) | ALDH1A1SMN1; SMN2CYP1A1CYP1B1CYP1A2 | |
| SCHEMBL6787725 | 0.79 | CYP1A1 (0.55) | ALDH1A1SMN1; SMN2ABCG2PTGS2MAOA | |
| SCHEMBL30185807 | 0.79 | CYP1A1 (0.55) | ALDH1A1SMN1; SMN2ABCG2PTGS2MAOA | |
| SCHEMBL26445244 | 0.78 | ABCG2 (0.64) | ALDH1A1SMN1; SMN2ABCG2PTGS2MAOA | |
| SCHEMBL1877387 | 0.77 | ABCG2 (0.68) | ALDH1A1SMN1; SMN2ABCG2PTGS2MAOA | |
| SCHEMBL1877390 | 0.77 | ABCG2 (0.68) | ALDH1A1SMN1; SMN2ABCG2PTGS2MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6828316-B2 | Antiallergens | KOWA CO., LTD. (JP) | 2004-12-07 | — | — | US | disclosed |
| US-20020042414-A1 | Diamide compound and medicine containing the same | KOWA CO., LTD. (JP) | 2002-04-11 | — | — | US | disclosed |
| US-6340682-B1 | FOR THERAPY OF ALLERGIC IMMUNOLOGICAL DISEASE IS SELECTED FROM ASTHMA, ALLERGIC RHINITIS, INFLAMMATORY LARGE BOWEL DISEASE OR CONTACT DERMATITIS | KOWA CO., LTD. (JP) | 2002-01-22 | — | — | US | disclosed |
| EP-0926138-A1 | DIAMIDE COMPOUNDS AND DRUGS CONTAINING THE SAME | KOWA CO. LTD. (JP) | 1999-06-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020042414-A1 | Diamide compound and medicine containing the same | HRH4, HRH2, HRH1 | ALDH1A1 836/4885SMN1; SMN2 4780/4885ABCG2 680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.